From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Project cooperationUpdated on 25 May 2026

Circular Bio-based economy, Pillar II-Horizon Europe, 21 April 2026, Brussels

CEO, Founder at citrusgenetics

Gastouni, Greece

About

The group works on key-unsolved problems of the astrobiology sector and produces innovative agri-food products, via organic farming and green cyclic economy approaches. Besides our entrepreneurial portfolio, molecular diagnostics tools & services are provided. Last but not least , one of our primary focuses is trees' breeding towards a. hardening, and b. novel cultivars characterisation, due to climatic change and pathogens' burst.The enterprise supports fair-trade and a libertarian spirit, under a communal concept.

Customers, VCs, partners traction for our plant biotech/deeptech start-up –

1.We can provide organic raw material as bio-producers.

2.We develop organic and hardened trees.

3.Resistant trees against CTV via RNA vaccines; non-GMO approach

  1. Novel fermentation modalities; plant-based MVP

  2. Antibody-like activities by natural microbiome

To participate in Horizon Proposals and coherent consortia

HORIZON-JU-CBE-2026-IAFlag-02: SsbD:Bio-based alternatives for fertilising and/or crop protection products (coordinator).

-We can provide and develop organic and hardened/certified trees (novel cultivars by trees' breeding/grafting/crossings/tissue culture and nursery installations. RNA edible vaccines)-non GMO approach against CTV/resistant trees

HORIZON-JU-CBE-2026-IAFlag-04: Diversification of nutritional food ingredient sources for increased EU resilience and strategic autonomy (participant)

- We can provide and develop organic tree fruits, aromatic olive oil and innovative distilled spirits.

HORIZON-JU-CBE-2026-CSA-01: Supporting industry in the switch to sustainable and circular bio based products and processes (participant)

- We can provide and develop novel microbiome strains for cyclic bio-process.

--

specifications

Running package: Molecular pharming via a tree organic bioreactor commodity x RNA bioenergetics modality.

Similar opportunities